Publications for Kerstin Willander
Co-author map based on ISI articles 2007-

Keywords

survival stage risk prognostic polymorphism patients p53 overall os mutations mutated mdm2snp309 mdm2 lymphocytic leukemia genes cll chronic cells aml

Journal Articles

Ingrid Jakobsen Falk, Kerstin Willander, Roza Chaireti, Johan Lund, Hareth Nahi, Monica Hermanson, Henrik Green, Kourosh Lotfi and Peter Söderkvist
  TP53 mutations and MDM2(SNP309) identify subgroups of AML patients with impaired outcome
  European Journal of Haematology, 2015, 94(4), 355-362.

Axel Benner, Larry Mansouri, Davide Rossi, Aneela Majid, Kerstin Willander, Anton Parker, Gareth Bond, Sarka Pavlova, Holger Nueckel, Olaf Merkel, Paolo Ghia, Emili Montserrat, Mohd Arifin Kaderi, Richard Rosenquist, Gianluca Gaidano, Martin J. S. Dyer, Peter Söderkvist, Mats Linderholm, David Oscier, Zuzana Tvaruzkova, Sarka Pospisilova, Ulrich Duehrsen, Richard Greil, Hartmut Doehner, Stephan Stilgenbauer and Thorsten Zenz
  MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis
  Haematologica (online), 2014, 99(8), 1285-1291.

Kerstin Willander, Ingrid Jakobsen Falk, Roza Chaireti, Esbjörn Paul, Hermanson Monica, Henrik Gréen, Kourosh Lotfi, Peter Söderkvist and Henrik Green
  Mutations in the isocitrate dehydrogenase 1/2 genes and IDH1 SNP 105C>T have a prognostic value in acute myeloid leukemia
  Biomarker Research, 2014, , .

Kerstin Willander, Ravi Kumar Dutta, Jonas Ungerbäck, Rebeqa Gunnarsson, Gunnar Juliusson, Mats Fredrikson, Mats Linderholm and Peter Söderkvist
  NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients
  BMC Cancer, 2013, 13, .
   Fulltext  PDF  
 Web of Science® Times Cited: 5

Kerstin Willander, Jonas Ungerbäck, Karin Karlsson, Mats Fredrikson, Peter Söderkvist and Mats Linderholm
  MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia
  European Journal of Haematology, 2010, 85(3), 251-256.
 Web of Science® Times Cited: 13

Anna Lanemo Myhrinder, Eva Hellqvist, Ekaterina Sidorova, Anita Söderberg, Helen Baxendale, Charlotte Dahle, Kerstin Willander, Gerard Tobin, Eva Bäckman, Ola Söderberg, Richard Rosenquist, Sohvi Hörkko and Anders Rosén
  A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies
  Blood, 2008, 111(7), 3838-3848.
 Web of Science® Times Cited: 120

Pernilla Eliasson, Patiyan Andersson, Kerstin Willander, Mats Linderholm, Peter Söderkvist and Jan-Ingvar Jönsson
  Letter: Absence of hot spot mutations of the PIK3CA gene in acute myeloid leukaemia
  European Journal of Haematology, 2006, 77(1), 86-87.
 Web of Science® Times Cited: 8

Gerard Tobin, Ulf Thunberg, Anna Laurell, Karin Karlsson, Anna Åleskog, Kerstin Willander, Ola Söderberg, Mats Merup, Juhani Vilpo, Magnus Hultdin, Christer Sundström, Göran Roos and Richard Rosenquist
  Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome
  Haematologica, 2005, 90(4), 465-469.
 Web of Science® Times Cited: 18

Gerard Tobin, Ulf Thunberg, Karin Karlsson, Fiona Murray, Anna Laurell, Kerstin Willander, Gunilla Enblad, Mats Merup, Juhani Vilpo, Gunnar Juliusson, Christer Sundström, Ola Söderberg, Göran Roos and Richard Rosenquist
  Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia
  Blood, 2004, 104, 2879-2885.
 Web of Science® Times Cited: 161

Ph.D. Theses

Kerstin Willander
  Molecular genetic studies on Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia - with focus on prognostic markers
  2014.


  Fulltext PDF